IN-VITRO EVALUATION OF DRUG SUSCEPTIBILITIES OF BABESIA DIVERGENS ISOLATES

Citation
P. Brasseur et al., IN-VITRO EVALUATION OF DRUG SUSCEPTIBILITIES OF BABESIA DIVERGENS ISOLATES, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 818-820
Citations number
17
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
42
Issue
4
Year of publication
1998
Pages
818 - 820
Database
ISI
SICI code
0066-4804(1998)42:4<818:IEODSO>2.0.ZU;2-T
Abstract
The susceptibilities of three bovine and two human Babesia divergens i solates to antimicrobial agents were evaluated in vitro by a tritiated hypoxanthine incorporation assay. The MICs at which 50% of isolates a re inhibited (MIC(50)s) for mefloquine (chlorhydrate), chloroquine (su lfate), quinine (chlorhydrate), clindamycin (phosphate), pentamidine ( isethionate), phenamidine (isethionate) plus oxomemazine (chlorhydrate ), lincomycin (chlorhydrate monohydrate), and imidocarb (dipropionate) were determined. Except for imidocarb, the MIC(50)s observed for the different isolates were close. Imidocarb and the combination of phenam idine plus oxomemazine exhibited the highest in vitro activity, while antimalarial agents such as mefloquine, choroquine, and quinine were i nactive. Other drugs had intermediate activities. The data support fur ther in vitro evaluation of antimicrobial agents active against B. div ergens for the improvement of therapeutic strategies.